BioNTech CEO: I consider this vaccine 'near perfect'
by from CNN.com - RSS Channel - App International Edition on (#57WCX)
Ugur Sahin, CEO and co-founder of BioNTech, tells CNN's Fred Pleitgen that the U.S.-German cooperation of Pfizer and BioNTech could have a Covid-19 vaccine ready for regulatory approval by the middle of October.